Company intelligence / Profile preview

USA MINGER

Sheridan, Wyoming, USA

Ownership: Private
Development stage: Other

Overview

USA Minger is a pharmaceutical company focused on the distribution and labeling of over-the-counter (OTC) topical anesthetic products. The company's portfolio includes the Npag Tattoo Numbing Cream and TKTX Numb series, which are formulated with local anesthetics such as procaine, tetracaine, and prilocaine. These products are primarily marketed for pain relief during cutaneous procedures, including tattooing and minor skin irritations. Headquartered in Sheridan, Wyoming, USA Minger operates under the FDA's OTC Monograph Drug program and maintains several active National Drug Codes (NDCs) for its topical formulations.

Therapeutic areas: NeurologyOther
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on USA MINGER.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on USA MINGER.

Explore the full profile